Furoscix ReadyFlow™ Furoscix ReadyFlow™ Furoscix ReadyFlow™ Furoscix ReadyFlow™ New analyses on Furoscix ReadyFlow PK/PD performance delivered via an autoinjector demonstrated...
PRINCETON, N.J., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) (the “Company”) today announced the pricing of...
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines...
Singapore, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today closed its registered direct...
SINGAPORE, Oct. 09, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (the “Company”) (NASDAQ: GDTC), a Singapore-based clinical stage biopharmaceutical company...
ALISO VIEJO, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a...
SAN CARLOS, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today...
HOUSTON, Oct. 09, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (NASDAQ: YMAT) (“J-Star” or the “Company”), an advanced composite...
Preclinical Results at Sheba Medical Center Demonstrate Retinal Recovery with NurExone’s Exosome-based Lead CandidateTORONTO and HAIFA, Israel, Oct. 09, 2026...
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization DALLAS, TX, Oct....
Lakewood, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today...
RadiusXR and Topcon Healthcare, Inc. unveil InspirePRO at AAO: the full measurement range expertly engineered into a lightweight wearable experience....
Partnership builds on Metro ENT’s established physician leadership while adding the resources and infrastructure of the National Breathe Free network.MESQUITE,...
PRESS RELEASE AB SCIENCE REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 AND KEY EVENTS OF THE PERIOD...
Third-Quarter 2026 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure...
Transcom's Retail Peak Resilience Index finds cost per order can triple while order volume doubles in operating models tuned to...
- New analyses from the pivotal Launch-HTN trial showed that 46% of participants with difficult-to-treat hypertension receiving lorundrostat 50 mg...
Shares expected to begin trading on split-adjusted basis on October 14, 2026LONG BEACH, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) --...
Communication with FDA at recent Type B meeting provided clear guidance for next steps to prepare IND application to support...
Veteran retina commercial leader, who has helped launch BEOVU®, EYLEA® and EYLEA® HD, to lead U.S. commercialization of LYTENAVA™ (bevacizumab-vikg)ISELIN,...